Diligence memo · auto-generated · as of July 2, 2026
Emerald Health Sciences Inc.
Emerald Health Sciences Inc. looks under-valued against its niche peers and is dormant on financing cadence.
Businessfiled
Emerald Health Sciences Inc. operates in Healthtech, based in VANCOUVER.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Emerald Health Sciences Inc. has raised $15M in disclosed capital across 5 recorded rounds, aggregated from public filings. Its latest round is modeled as Series A (a $4.0M–$15M round).
Largest single filing: $9.9M on 2015-12-31.
Most recent recorded round closed around 2019-01-08.
Valuation (modeled)modeled
Provath models Emerald Health Sciences Inc. at approximately $8.1M (range $461K–$44M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Under-valued. Modeled value is 0.07× the median modeled value of Series A Healthtech companies in 2019–2021 (124 peers) — value vs value, same stage and era.
Financing rhythm & timingmixed
Historic cadence: a new round about every 12 months.
Last raise 7.5 yr ago; this sector typically re-raises about every 14 months.
Silent for over 3× the sector's normal cadence.
The last round was 11.2× smaller than the prior — a bridge or down round.
Comparablesmixed
Capital scale ranks ahead of 76% of Healthtech peers (2138 compared).
Modeled value ranks above 30% of those peers.
Closest niche peers: Itamar Medical Ltd., ChartSpan Medical Technologies, Inc., 4G Clinical, LLC, Wellness Group Investors, LLC, Avation Medical, Inc..
Peoplefiled
3 named people on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.